Corcept Therapeutics, Inc. (CORT) Posts Narrower than Expected Q2 Loss of 9c/Share
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $91.88 -1.47%
EPS Growth %: -96.6%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
CCEL, FEIM, PLG, More
EPS Growth %: -96.6%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q2 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
- Delta Air shares slip despite strong outlook, Melius says
- Buy the pullback in this major pharma stock: Bernstein
Create E-mail Alert Related Categories
Earnings, Trading HaltsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
